SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024
SeaStar Medical Holding (Nasdaq: ICU), a commercial-stage medical device company, will present at NobleCon20, Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference.
The presentation is scheduled for Wednesday, December 4, 2024, at 12:00 p.m. Eastern time (9:00 a.m. Pacific time) in Boca Raton, Fla. The company will provide an overview of its proprietary solutions aimed at reducing the consequences of hyperinflammation on vital organs.
A webcast of the presentation will be available on the company's website starting December 5 and will be archived for 90 days.
SeaStar Medical Holding (Nasdaq: ICU), un'azienda di dispositivi medici in fase commerciale, presenterà al NobleCon20, la 20ª Conferenza Annuale sulle Azioni di Crescita Emergente di Noble Capital Markets.
La presentazione è programmata per mercoledì 4 dicembre 2024, alle 12:00 (ora orientale) (9:00 ora del pacifico) a Boca Raton, Florida. L'azienda fornirà una panoramica delle sue soluzioni proprietarie volte a ridurre le conseguenze dell'iperinfiammazione sugli organi vitali.
Un webcast della presentazione sarà disponibile sul sito web dell'azienda a partire dal 5 dicembre e sarà archiviato per 90 giorni.
SeaStar Medical Holding (Nasdaq: ICU), una empresa de dispositivos médicos en etapa comercial, se presentará en NobleCon20, la 20ª Conferencia Anual de Crecimiento Emergente de Noble Capital Markets.
La presentación está programada para miércoles 4 de diciembre de 2024, a las 12:00 p.m. hora del este (9:00 a.m. hora del pacífico) en Boca Raton, Florida. La empresa proporcionará una visión general de sus soluciones patentadas destinadas a reducir las consecuencias de la hiperinflamación en los órganos vitales.
Una transmisión web de la presentación estará disponible en el sitio web de la empresa a partir del 5 de diciembre y se archivará durante 90 días.
SeaStar Medical Holding (Nasdaq: ICU), 상업 단계의 의료 기기 회사가 NobleCon20, Noble Capital Markets의 제20회 연례 신흥 성장 주식 회의에서 발표할 예정입니다.
발표는 2024년 12월 4일 수요일, 동부 표준시 기준으로 오후 12시(태평양 표준시 기준으로 오전 9시)에 플로리다 주 보카 레이턴에서 예정되어 있습니다. 회사는 중요한 장기에 대한 과도한 염증의 결과를 줄이기 위한 독창적인 솔루션 개요를 제공할 것입니다.
발표의 웹 캐스트는 12월 5일부터 회사 웹사이트에서 이용 가능하며 90일 동안 아카이브됩니다.
SeaStar Medical Holding (Nasdaq: ICU), une entreprise de dispositifs médicaux en phase commerciale, présentera à NobleCon20, la 20ème Conférence Annuelle sur les Actions de Croissance Émergente de Noble Capital Markets.
La présentation est prévue pour le mercredi 4 décembre 2024, à 12h00 heure de l'Est (9h00 heure du Pacifique) à Boca Raton, Floride. L'entreprise fournira un aperçu de ses solutions propriétaires visant à réduire les conséquences de l'hyperinflammation sur les organes vitaux.
Une retransmission en direct de la présentation sera disponible sur le site web de l'entreprise à partir du 5 décembre et sera archivée pendant 90 jours.
SeaStar Medical Holding (Nasdaq: ICU), ein Unternehmen für medizinische Geräte in der Handelsphase, wird auf der NobleCon20, der 20. jährlichen Konferenz für wachstumsstarke Emerging Markets von Noble Capital Markets, präsentieren.
Die Präsentation ist für Mittwoch, den 4. Dezember 2024, um 12:00 Uhr Eastern Time (9:00 Uhr Pacific Time) in Boca Raton, Florida, geplant. Das Unternehmen wird einen Überblick über seine proprietären Lösungen geben, die darauf abzielen, die Folgen von Hyperinflammation auf lebenswichtige Organe zu reduzieren.
Ein Webcast der Präsentation wird ab dem 5. Dezember auf der Unternehmenswebsite verfügbar sein und für 90 Tage archiviert.
- None.
- None.
DENVER, Nov. 26, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that management will present a company overview at NobleCon20, Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference, on Wednesday, December 4 at 12:00 p.m. Eastern time (9:00 a.m. Pacific time). The conference is being held in Boca Raton, Fla.
A webcast of the presentation will be available beginning December 5 on the Company website and will be archived for 90 days.
About SeaStar Medical
SeaStar Medical is a commercial-stage medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical’s novel technologies rely on science and innovation to provide life-saving solutions to critically ill patients. The Company is developing and commercializing cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. For more information visit www.seastarmedical.com or visit us on LinkedIn or X.
Contact:
Alliance Advisors IR
Jody Cain
(310) 691-7100
Jcain@allianceadvisors.com
# # #
FAQ
When is SeaStar Medical presenting at NobleCon20?
Where is NobleCon20 being held?
What is the stock symbol for SeaStar Medical?
When will the webcast of SeaStar Medical's presentation be available?
How long will the webcast of SeaStar Medical's presentation be archived?
